Gender Medicine: Effects of Sex and Gender on Cardiovascular Disease Manifestation and Outcomes

Overview

Journal Nat Rev Cardiol

Specialty Cardiology & Vascular Diseases

Date 2022 Nov 1

PMID 36316574

Authors

Vera Regitz-Zagrosek

Catherine Gebhard

Affiliations

Soon will be listed here.

Abstract

Despite a growing body of evidence, the distinct contributions of biological sex and the sociocultural dimension of gender to the manifestations and outcomes of ischaemic heart disease and heart failure remain unknown. The intertwining of sex-based differences in genetic and hormonal mechanisms with the complex dimension of gender and its different components and determinants that result in different disease phenotypes in women and men needs to be elucidated. The relative contribution of purely biological factors, such as genes and hormones, to cardiovascular phenotypes and outcomes is not yet fully understood. Increasing awareness of the effects of gender has led to efforts to measure gender in retrospective and prospective clinical studies and the development of gender scores. However, the synergistic or opposing effects of sex and gender on cardiovascular traits and on ischaemic heart disease and heart failure mechanisms have not yet been systematically described. Furthermore, specific considerations of sex-related and gender-related factors in gender dysphoria or in heart-brain interactions and their association with cardiovascular disease are still lacking. In this Review, we summarize contemporary evidence on the distinct effects of sex and gender as well as of their interactions on cardiovascular disease and how they favourably or unfavourably influence the pathogenesis, clinical manifestations and treatment responses in patients with ischaemic heart disease or heart failure.

Citing Articles

The role of estrogen in the sex difference for the risk factors of heart failure with preserved ejection fraction.

Du J, Liu J, Wang X, Wang X, Ma Y, Zhang S Biol Direct. 2025; 20(1):28.

PMID: 40065410 PMC: 11895175. DOI: 10.1186/s13062-025-00618-x.

Identification and validation of key genes associated with cell senescence in acute myocardial infarction.

Zhao W, Zhu G, Chu T, Wu L, Li H, Zhen Q Front Cardiovasc Med. 2025; 12:1499157.

PMID: 40046960 PMC: 11880263. DOI: 10.3389/fcvm.2025.1499157.

The multifaceted challenges faced by women in the field of inherited metabolic disorders.

Lenzini L, Bianconi S, Gugelmo G, Gragnaniello V, Messerotti Benvenuti S, Fadini G Orphanet J Rare Dis. 2025; 20(1):104.

PMID: 40045394 PMC: 11881448. DOI: 10.1186/s13023-025-03604-8.

Getting to the Heart of the Matter: Exploring the Intersection of Cardiovascular Disease, Sex and Race and How Exercise, and Gut Microbiota Influence these Relationships.

Guers J, Heffernan K, Campbell S Rev Cardiovasc Med. 2025; 26(2):26430.

PMID: 40026503 PMC: 11868917. DOI: 10.31083/RCM26430.

Catalysing change in health and medical research policy: an Australian case study of deliberative democracy to reform sex and gender policy recommendations.

Haupt S, Carcel C, Halliday L, Billiards S, Carson L, Redman K Front Public Health. 2025; 12:1522213.

PMID: 40012581 PMC: 11861193. DOI: 10.3389/fpubh.2024.1522213.

References

Mosca L, Navar A, Wenger N . Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020. J Womens Health (Larchmt). 2020; 29(8):1091-1100. PMC: 7476379. DOI: 10.1089/jwh.2019.8189. View

Cammann V, Szawan K, Stahli B, Kato K, Budnik M, Wischnewsky M . Age-Related Variations in Takotsubo Syndrome. J Am Coll Cardiol. 2020; 75(16):1869-1877. DOI: 10.1016/j.jacc.2020.02.057. View

Lee C, Mnatzaganian G, Woodward M, Chow C, Sitas F, Robinson S . Sex disparities in the management of coronary heart disease in general practices in Australia. Heart. 2019; 105(24):1898-1904. DOI: 10.1136/heartjnl-2019-315134. View

Shannon G, Jansen M, Williams K, Caceres C, Motta A, Odhiambo A . Gender equality in science, medicine, and global health: where are we at and why does it matter?. Lancet. 2019; 393(10171):560-569. DOI: 10.1016/S0140-6736(18)33135-0. View

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

Komesaroff P, Esler M, Sudhir K . Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 1999; 84(2):606-10. DOI: 10.1210/jcem.84.2.5447. View

Gebhard C, Maredziak M, Portmann A, Bengs S, Haider A, Fiechter M . Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2019; 46(10):2032-2041. DOI: 10.1007/s00259-019-04344-1. View

Hartman R, Owsiany K, Ma L, Koplev S, Hao K, Slenders L . Sex-Stratified Gene Regulatory Networks Reveal Female Key Driver Genes of Atherosclerosis Involved in Smooth Muscle Cell Phenotype Switching. Circulation. 2021; 143(7):713-726. PMC: 7930467. DOI: 10.1161/CIRCULATIONAHA.120.051231. View

Hartman R, Kapteijn D, Haitjema S, Bekker M, Mokry M, Pasterkamp G . Intrinsic transcriptomic sex differences in human endothelial cells at birth and in adults are associated with coronary artery disease targets. Sci Rep. 2020; 10(1):12367. PMC: 7378217. DOI: 10.1038/s41598-020-69451-8. View

10.

Mehta P, Lima B, Nelson M, Merz C . Adverse cardiovascular outcomes in women: blame the amygdala?. Eur Heart J Cardiovasc Imaging. 2019; 20(6):633-635. PMC: 6529906. DOI: 10.1093/ehjci/jez086. View

11.

Dart A, Du X, Kingwell B . Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res. 2002; 53(3):678-87. DOI: 10.1016/s0008-6363(01)00508-9. View

12.

Nielsen M, Stefanick M, Peragine D, Neilands T, Ioannidis J, Pilote L . Gender-related variables for health research. Biol Sex Differ. 2021; 12(1):23. PMC: 7898259. DOI: 10.1186/s13293-021-00366-3. View

13.

. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42(25):2439-2454. PMC: 8248998. DOI: 10.1093/eurheartj/ehab309. View

14.

Robinson G, Peng J, Peckham H, Radziszewska A, Butler G, Pineda-Torra I . Sex hormones drive changes in lipoprotein metabolism. iScience. 2021; 24(11):103257. PMC: 8567005. DOI: 10.1016/j.isci.2021.103257. View

15.

Wren G, Davies W . Sex-linked genetic mechanisms and atrial fibrillation risk. Eur J Med Genet. 2022; 65(4):104459. DOI: 10.1016/j.ejmg.2022.104459. View

16.

Hellgren T, Blondal M, Jortveit J, Ferenci T, Faxen J, Lewinter C . Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries. Eur Heart J Open. 2022; 2(4):oeac042. PMC: 9283107. DOI: 10.1093/ehjopen/oeac042. View

17.

Greenwood B, Carnahan S, Huang L . Patient-physician gender concordance and increased mortality among female heart attack patients. Proc Natl Acad Sci U S A. 2018; 115(34):8569-8574. PMC: 6112736. DOI: 10.1073/pnas.1800097115. View

18.

Phillips S . Defining and measuring gender: a social determinant of health whose time has come. Int J Equity Health. 2005; 4:11. PMC: 1180842. DOI: 10.1186/1475-9276-4-11. View

19.

Tawakol A, Ishai A, Takx R, Figueroa A, Ali A, Kaiser Y . Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017; 389(10071):834-845. PMC: 7864285. DOI: 10.1016/S0140-6736(16)31714-7. View

20.

Mehta P, Quesada O, Al-Badri A, Fleg J, Volgman A, Pepine C . Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease. Int J Cardiol. 2021; 348:1-8. PMC: 8779638. DOI: 10.1016/j.ijcard.2021.12.013. View